ACCURAY INCORPORATED Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
ACCURAY INCORPORATED (ARAY) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $13.70 million for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-08.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2023-05-08
- ACCURAY INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $500.00K, a 0.00% change year-over-year.
- ACCURAY INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-12-31 was $1.00M, a 58.33% decline year-over-year.
- ACCURAY INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-09-30 was $12.20M, a 1255.56% increase year-over-year.
- ACCURAY INCORPORATED right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-06-30 was $1.70M, a 466.67% increase year-over-year.
- ACCURAY INCORPORATED right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $3.20M, a 190.91% increase from fiscal 2021.
- ACCURAY INCORPORATED right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $1.10M, a 78.85% decline from fiscal 2020.
- ACCURAY INCORPORATED right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $5.20M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-03-31 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $1.50M derived: sum of 2 quarters · filed 2023-05-08 | $13.70M 10-Q · filed 2023-05-08 | $15.40M derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | $13.20M 10-Q · filed 2023-02-02 | $14.90M derived: sum of 3 quarters · filed 2023-02-02 | $15.40M derived: sum of 4 quarters · filed 2023-02-02 |
| 2022-09-30 | $12.20M 10-Q · filed 2022-11-03 | $13.90M derived: sum of 2 quarters · filed 2022-11-03 | $14.40M derived: sum of 3 quarters · filed 2022-11-03 | $16.80M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-17 | $2.20M derived: sum of 2 quarters · filed 2022-08-17 | $4.60M derived: sum of 3 quarters · filed 2022-08-17 | $3.20M 10-K · filed 2022-08-17 |
| 2022-03-31 | $500.00K 10-Q · filed 2022-04-29 | $2.90M derived: sum of 2 quarters · filed 2022-04-29 | $1.50M 10-Q · filed 2023-05-08 | $4.10M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $2.40M 10-Q · filed 2022-01-28 | $4.90M 10-Q · filed 2023-02-02 | $3.60M derived: sum of 3 quarters · filed 2022-11-03 | $3.80M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-09-30 | $900.00K 10-Q · filed 2022-11-03 | $1.20M derived: sum of 2 quarters · filed 2022-11-03 | $1.40M derived: sum of 3 quarters · filed 2022-11-03 | $1.80M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-17 | $500.00K derived: sum of 2 quarters · filed 2022-08-17 | $900.00K derived: sum of 3 quarters · filed 2022-08-17 | $1.10M 10-K · filed 2022-08-17 |
| 2021-03-31 | $200.00K 10-Q · filed 2022-04-29 | $600.00K derived: sum of 2 quarters · filed 2022-04-29 | $800.00K 10-Q · filed 2022-04-29 | $1.60M derived: sum of 4 quarters · filed 2022-04-29 |
| 2020-12-31 | $400.00K 10-Q · filed 2022-01-28 | $600.00K 10-Q · filed 2022-01-28 | $1.40M derived: sum of 3 quarters · filed 2022-01-28 | $2.10M derived: sum of 4 quarters · filed 2022-01-28 |
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-04 | $1.00M derived: sum of 2 quarters · filed 2021-11-04 | $1.70M derived: sum of 3 quarters · filed 2021-11-04 | $5.20M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-17 | $1.50M derived: sum of 2 quarters · filed 2021-08-17 | $5.00M derived: sum of 3 quarters · filed 2021-08-17 | $5.20M 10-K · filed 2021-08-17 |
| 2020-03-31 | $700.00K 10-Q · filed 2021-04-30 | $4.20M derived: sum of 2 quarters · filed 2021-04-30 | $4.40M 10-Q · filed 2021-04-30 | |
| 2019-12-31 | $3.50M 10-Q · filed 2021-02-01 | $3.70M 10-Q · filed 2021-02-01 | ||
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |